on ABIVAX (EPA:ABVX)
Abivax unveils its financial calendar for 2025
French biotech company Abivax has released its financial reporting calendar for 2025. The announcement includes several key dates for shareholders and investors. On March 24, the company will release its 2024 annual report, followed by Q1 2025 financial results on June 2. A general shareholders’ meeting is scheduled for June 6 in Paris.
The half-year and financial report will be presented on August 11, and the third quarter 2025 results will be communicated on December 15. These publications will be made after the close of the American market. These regular steps aim to inform investors of Abivax's financial developments throughout the year.
R. P.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all ABIVAX news